According to Aotai Biotech's announcement, as of July 17, 2026, the company had repurchased a total of 3.317,500 shares through centralized bidding transactions, accounting for 4.18% of the total share capital of 79.2809 million shares, an increase of 0.54% compared to the previous disclosure. The highest transaction price was 68.29 yuan/share, the lowest price was 41.88 yuan/share, and the total payment capital was 184 million yuan. The company will implement a repurchase on February 9, 2026, with an estimated amount of 100 million to 200 million yuan. The repurchase of shares will be used to reduce registered capital.

Zhitongcaijing · 1d ago
According to Aotai Biotech's announcement, as of July 17, 2026, the company had repurchased a total of 3.317,500 shares through centralized bidding transactions, accounting for 4.18% of the total share capital of 79.2809 million shares, an increase of 0.54% compared to the previous disclosure. The highest transaction price was 68.29 yuan/share, the lowest price was 41.88 yuan/share, and the total payment capital was 184 million yuan. The company will implement a repurchase on February 9, 2026, with an estimated amount of 100 million to 200 million yuan. The repurchase of shares will be used to reduce registered capital.